215 related articles for article (PubMed ID: 26258775)
21. RARγ is a negative regulator of osteoclastogenesis.
Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
[TBL] [Abstract][Full Text] [Related]
22. Notch2 Blockade Mitigates Methotrexate Chemotherapy-Induced Bone Loss and Marrow Adiposity.
Peymanfar Y; Su YW; Xian CJ
Cells; 2022 May; 11(9):. PubMed ID: 35563828
[TBL] [Abstract][Full Text] [Related]
23. Panax notoginseng saponins mitigate ovariectomy-induced bone loss and inhibit marrow adiposity in rats.
Fan JZ; Wang Y; Meng Y; Li GW; Chang SX; Nian H; Liang YJ
Menopause; 2015 Dec; 22(12):1343-50. PubMed ID: 26035148
[TBL] [Abstract][Full Text] [Related]
24. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
25. [Comparison research with icariin and genistein by anti-inflammatory reaction and angiogenesis pathway to inhibit bone loss on ovariectomized rats].
Cheng K; Chen KM; Ge BF; Zhen P; Gao YH; Ma HP
Zhong Yao Cai; 2014 Apr; 37(4):627-31. PubMed ID: 25345138
[TBL] [Abstract][Full Text] [Related]
26. Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats.
Fan CM; Su YW; Howe PR; Xian CJ
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415482
[TBL] [Abstract][Full Text] [Related]
27. Antiosteoporotic activity of echinacoside in ovariectomized rats.
Li F; Yang X; Yang Y; Guo C; Zhang C; Yang Z; Li P
Phytomedicine; 2013 Apr; 20(6):549-57. PubMed ID: 23428402
[TBL] [Abstract][Full Text] [Related]
28. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
29. Bone-targeted methotrexate-alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo.
Xie Z; Liu G; Tang P; Sun X; Chen S; Qin A; Zhu P; Zhang J; Fan S
Drug Deliv; 2018 Nov; 25(1):187-197. PubMed ID: 29303005
[TBL] [Abstract][Full Text] [Related]
30. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats.
Segawa Y; Yamaura M; Aota S; Omata T; Tuzuike N; Itokazu Y; Oka H; Tamaki H; Nakamura T
Bone; 1997 May; 20(5):457-64. PubMed ID: 9145243
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate chemotherapy triggers touch-evoked pain and increased CGRP-positive sensory fibres in the tibial periosteum of young rats.
Zhou FH; Yu Y; Zhou XF; Xian CJ
Bone; 2015 Apr; 73():24-31. PubMed ID: 25479342
[TBL] [Abstract][Full Text] [Related]
33. The phytoestrogen genistein prevents trabecular bone loss and affects thyroid follicular cells in a male rat model of osteoporosis.
Filipović B; Šošić-Jurjević B; Ajdžanović V; Živanović J; Manojlović-Stojanoski M; Nestorović N; Ristić N; Trifunović S; Milošević V
J Anat; 2018 Aug; 233(2):204-212. PubMed ID: 29761487
[TBL] [Abstract][Full Text] [Related]
34. Estrogen-mimicking isoflavone genistein prevents bone loss in a rat model of obstructive sleep apnea-hypopnea syndrome.
Song L; Liang X; Zhou Y
Int J Clin Exp Pathol; 2014; 7(4):1687-94. PubMed ID: 24817965
[TBL] [Abstract][Full Text] [Related]
35. Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids.
Koppelmann T; Pollak Y; Mogilner J; Bejar J; Coran AG; Sukhotnik I
Br J Nutr; 2013 Jan; 109(1):89-98. PubMed ID: 22456439
[TBL] [Abstract][Full Text] [Related]
36. Effects of silymarin on methotrexate-induced nephrotoxicity in rats.
Dabak DO; Kocaman N
Ren Fail; 2015 May; 37(4):734-9. PubMed ID: 25707519
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of hispidulin, genistein, and icariin with estrogen on bone tissue in ovariectomized rats.
Yang L; Yu Z; Qu H; Li M
Cell Biochem Biophys; 2014 Sep; 70(1):485-90. PubMed ID: 24748177
[TBL] [Abstract][Full Text] [Related]
39. The short- and long-term effects of methotrexate on the rat skeleton.
Wheeler DL; Vander Griend RA; Wronski TJ; Miller GJ; Keith EE; Graves JE
Bone; 1995 Feb; 16(2):215-21. PubMed ID: 7756050
[TBL] [Abstract][Full Text] [Related]
40. The influence of leptin on trabecular architecture and marrow adiposity in GH-deficient rats.
Evans BA; Bull MJ; Kench RC; Fox RE; Morgan LD; Stevenson AE; Gevers EF; Perry MJ; Wells T
J Endocrinol; 2011 Jan; 208(1):69-79. PubMed ID: 20962012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
